Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme

[1]  L. V. van de Poll-Franse,et al.  Fatigue among short- and long-term thyroid cancer survivors: results from the population-based PROFILES registry. , 2013, Thyroid : official journal of the American Thyroid Association.

[2]  A. Dietz,et al.  Quality of Life Correlates After Surgery for Laryngeal Carcinoma , 2007, The Laryngoscope.

[3]  S. Balasubramanian,et al.  Treatment related morbidity in differentiated thyroid cancer–a survey of clinicians , 2014, Thyroid Research.

[4]  M. Wolzt,et al.  Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy , 2003, Supportive Care in Cancer.

[5]  B. Weintraub,et al.  A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. , 2006, The Journal of clinical endocrinology and metabolism.

[6]  J. Kronenberg,et al.  Quality of life of well-differentiated thyroid carcinoma patients , 2004, The Journal of Laryngology & Otology.

[7]  A. Bockisch,et al.  Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment. , 2005, European journal of endocrinology.

[8]  Barbara Weber,et al.  The Computer-based Health Evaluation Software (CHES): a software for electronic patient-reported outcome monitoring , 2012, BMC Medical Informatics and Decision Making.

[9]  M. Vaisman,et al.  Quality of Life, Muscle Strength, and Fatigue Perception in Patients on Suppressive Therapy With Levothyroxine for Differentiated Thyroid Carcinoma , 2013, American journal of clinical oncology.

[10]  P. Laurberg,et al.  Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. , 2002, The Journal of clinical endocrinology and metabolism.

[11]  M. Luster,et al.  Recombinant human thyrotropin: safety and quality of life evaluation. , 2012, Journal of endocrinological investigation.

[12]  C. McCudden,et al.  The Challenges and Complexities of Thyroid Hormone Replacement , 2010 .

[13]  A. Katalinic,et al.  Normative Data of the EORTC QLQ-C30 For the German Population: A Population-Based Survey , 2013, PloS one.

[14]  H. Sintonen,et al.  Health‐related quality of life in long‐term follow‐up of patients with cured TNM Stage I or II differentiated thyroid carcinoma , 2009, Clinical endocrinology.

[15]  J. Coebergh,et al.  Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: A study from the population-based PROFILES registry , 2013, Acta oncologica.

[16]  L. V. van de Poll-Franse,et al.  Health‐related quality of life among thyroid cancer survivors: a systematic review , 2011, Clinical endocrinology.

[17]  Gregory Kaltsas,et al.  Fatigue, Endocrinopathies, and Metabolic Disorders , 2010, PM & R : the journal of injury, function, and rehabilitation.

[18]  A. Gafni,et al.  The Impact of Thyroid Cancer and Post-Surgical Radioactive Iodine Treatment on the Lives of Thyroid Cancer Survivors: A Qualitative Study , 2009, PloS one.

[19]  M. Luster,et al.  Results of the Thyroid Cancer Alliance international patient/survivor survey: Psychosocial/informational support needs, treatment side effects and international differences in care , 2013, Hormones.

[20]  H. Wang,et al.  Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis. , 2015, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[21]  Soo Hyun Kim,et al.  Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea , 2010, Health and quality of life outcomes.

[22]  Ying Lin,et al.  Recombinant human thyrotropin-aided versus thyroid hormone withdrawal-aided radioiodine treatment for differentiated thyroid cancer after total thyroidectomy: a meta-analysis. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  A. Loundou,et al.  Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study , 2009, Clinical endocrinology.

[24]  J. Romijn,et al.  Autonomic nervous system function in chronic exogenous subclinical thyrotoxicosis and the effect of restoring euthyroidism. , 2008, The Journal of clinical endocrinology and metabolism.

[25]  Marija Despot,et al.  The most common factors influencing on quality of life of thyroid cancer patients after thyroid hormone withdrawal. , 2014, Psychiatria Danubina.

[26]  J. Ferlay,et al.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. , 2013, European journal of cancer.

[27]  A. Hinz,et al.  Quality of life in patients with thyroid cancer compared with the general population. , 2012, Thyroid : official journal of the American Thyroid Association.

[28]  G. Kemmler,et al.  Are gender-associated differences in quality of life in colorectal cancer patients disease-specific? , 2009, Quality of Life Research.

[29]  M. Schlumberger,et al.  Strategies of radioiodine ablation in patients with low-risk thyroid cancer. , 2012, The New England journal of medicine.

[30]  S. Ezzat,et al.  Persistent posttreatment fatigue in thyroid cancer survivors: a scoping review. , 2014, Endocrinology and metabolism clinics of North America.

[31]  J. Franklyn,et al.  Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. , 2012, The New England journal of medicine.

[32]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[34]  R. Greil,et al.  Normative data for functional assessment of cancer therapy General scale and its use for the interpretation of quality of life scores in cancer survivors , 2004, Acta oncologica.

[35]  J. Easley,et al.  It's the "good" cancer, so who cares? Perceived lack of support among young thyroid cancer survivors. , 2013, Oncology nursing forum.

[36]  L. Kowalski,et al.  Clinical predictors of quality of life in patients with initial differentiated thyroid cancers. , 2009, Archives of otolaryngology--head & neck surgery.

[37]  L. Bastholt,et al.  A Placebo-Controlled, Blinded and Randomised Study on the Effects of Recombinant Human Thyrotropin on Quality of Life in the Treatment of Thyroid Cancer , 2013, European Thyroid Journal.

[38]  Juana Gómez,et al.  Using Polytomous Item Response Models to Assess Death Anxiety , 2007, Nursing research.